small molecule

COSOPT

DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE

Loss of exclusivity—loss of exclusivity

CompanyThea →See this company's full patent-cliff portfolio

Drug detail

Brand name	COSOPT
Active ingredient	DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE
Strength	EQ 2% BASE;EQ 0.5% BASE
Dosage form	SOLUTION/DROPS
Route	OPHTHALMIC
Modality	Small molecule
FDA approval	April 1998
Marketing status	RX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.